Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers

ClinicalTrials.gov ID: NCT02869789

Public ClinicalTrials.gov record NCT02869789. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 8:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b/4 Safety Trial of Flat Dose Nivolumab In Combination With Ipilimumab in Participants With Non-Small Cell Lung Cancer

Study identification

NCT ID
NCT02869789
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
1,041 participants

Conditions and interventions

Conditions

Interventions

  • Nivolumab in combination with Ipilimumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 4, 2016
Primary completion
May 12, 2022
Completion
May 12, 2022
Last update posted
Jun 14, 2023

2016 – 2022

United States locations

U.S. sites
61
U.S. states
26
U.S. cities
57
Facility City State ZIP Site status
Local Institution - 0121 Birmingham Alabama 35205
Local Institution - 0148 Phoenix Arizona 85016
Local Institution - 0085 Tucson Arizona 85704
Local Institution - 0164 Little Rock Arkansas 72205
Local Institution - 0146 Bakersfield California 93309
Marin Cancer Care, Inc Greenbrae California 94904
Los Angeles Hematology/Oncology Medical Group Los Angeles California 90017
Local Institution - 0115 Los Angeles California 90095
Torrance Health Association Redondo Beach California 90277
Va San Diego Healthcare System San Diego California 92161
Local Institution - 0143 San Luis Obispo California 93401
Local Institution - 0144 Santa Maria California 93454
Gene Upshaw Memorial Tahoe Forest Cancer Center Truckee California 96161
Local Institution - 0161 Whittier California 90603
Local Institution - 0083 Denver Colorado 80218
Local Institution - 0141 Grand Junction Colorado 81501
Cancer Specialists of North FL Jacksonville Florida 32207
Local Institution - 0082 Ocala Florida 34474
Local Institution - 0147 Pembroke Pines Florida 33028
Local Institution - 0163 Athens Georgia 30607
Local Institution - 0002 Atlanta Georgia 30322
Local Institution - 0166 Atlanta Georgia 30342
Local Institution - 0088 Niles Illinois 60714
Local Institution - 0108 Wichita Kansas 67214
Kentucky One Health St. Joseph East Cancer Center Lexington Kentucky 40509
Local Institution - 0091 Columbia Maryland 21044
Local Institution - 0089 Edina Minnesota 55435-2150
Jackson Oncology Associates, Pllc Jackson Mississippi 39202
Local Institution - 0077 Grand Island Nebraska 68803
Local Institution - 0087 Las Vegas Nevada 89148
Local Institution - 0170 Reno Nevada 89511
Local Institution - 0156 Belleville New Jersey 07109
Summit Medical Group Florham Park New Jersey 07932
Local Institution - 0142 Livingston New Jersey 07039
Local Institution - 0167 The Bronx New York 10461
Local Institution - 0004 Durham North Carolina 27710
Local Institution - 0012 Winston-Salem North Carolina 27157
Local Institution - 0100 Cincinnati Ohio 45242
Local Institution - 0134 Cleveland Ohio 44109
Local Institution - 0172 Corvallis Oregon 97330
Local Institution - 0096 Eugene Oregon 97401
Local Institution - 0176 Portland Oregon 97239
Local Institution - 0139 Allentown Pennsylvania 18103
Allegheny Health Network Pittsburgh Pennsylvania 15224
Local Institution - 0159 Pittsburgh Pennsylvania 15232
Local Institution - 0001 Sayre Pennsylvania 18840
Local Institution - 0123 Charleston South Carolina 29414
Local Institution - 0066 Chattanooga Tennessee 37404
Local Institution - 0067 Nashville Tennessee 37203
Local Institution - 0090 Austin Texas 78745
Texas Oncology, P.A. Dallas Texas 75230
Local Institution - 0149 Dallas Texas 75231
Local Institution - 0094 Fort Worth Texas 76104
Local Institution - 0093 Longview Texas 75601
Local Institution - 0098 Plano Texas 75075-7787
Local Institution - 0086 Waco Texas 76712
Local Institution - 0097 Fairfax Virginia 22031
Local Institution - 0044 Richmond Virginia 23230
Providence Regional Cancer Partnership Everett Washington 98201
Local Institution - 0174 Renton Washington 98055
Local Institution - 0173 Spokane Washington 99208

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 75 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02869789, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 14, 2023 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02869789 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →